Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time. By using a continuous glucose monitor, your CGM system will automatically receive glucose readings every 5 minutes allowing you to fingerstick less often. CGM can be used with or without an insulin pump.¶
What is Smart CGM?
Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform you of clinically relevant glucose patterns.†
What is Professional CGM?
Professional CGM is used by your healthcare provider and captures up to 288 glucose readings each day for up to six days and creates a personalized report that can help you better understand the cause and effect of your glucose variability.
Please visit the iPro™2 Professional CGM Evaluation page for more information.
A blood glucose meter only provides a brief “snapshot” of your glucose level at a single moment in time. A CGM system gives you a greater view of your glucose trends. CGM can provide valuable information 1 at crucial points during the day, including before and during exercise, prior to driving, before test/exam-taking, and in the middle of the night.
Medtronic offers CGM systems for people living with type 1 or type 2 diabetes that want better glucose control. CGM is especially beneficial for people who:4
Whether you manage your diabetes with a pump, multiple daily injections, oral medications or through diet and exercise, Medtronic offers CGM products and insulin pump systems that give you, your loved ones and healthcare professionals the insights to track and manage your diabetes on your terms.
To request a free insurance coverage check and learn more about your eligibility and potential out-of-pocket costs please complete the form below or call 1-888-350-5440 and one of our Diabetes Therapy consultants will be happy to assist you.
MiniMed™ 670G Insulin Pump and CGM system
An insulin pump combined with a CGM can enable your pump to automatically2 adjust your basal (background) insulin every five minutes based on your CGM readings#.
MiniMed™ 670G system includes our newest and most advanced CGM, the Guardian™ Sensor 3 and the Guardian™ Link 3 transmitter. It is the first and only system that constantly self-adjusts2 to automatically2 keep your sugar levels in range.
The MiniMed™ 670G system helps stabilize glucose levels with fewer highs and lows, so you can focus less on your diabetes and more on whatever the day brings.
For people using insulin injections
The Guardian™ Connect CGM monitors your glucose levels day and night and alerts you of highs or lows before they happen. You can set alerts anywhere from 10 to 60 minutes, getting notified exactly when you want. The system includes a small sensor worn up to seven days and a slim, discreet Bluetooth® transmitter. They work together to send precise glucose readings automatically to your phone every five minutes. The Smart CGM system comes with exclusive access to the Sugar.IQ diabetes assistant, that helps you understand your daily glucose patterns and identify activities affecting them—for a full picture of your diabetes.1
Guardian™ Connect CGM has you covered — and looks ahead — so you can focus on living your life, instead of watching your glucose levels.
A simple way to better control your diabetes.
The iPro™2 Professional CGM system records your glucose levels 24 hours a day for up to six days. Used intermittently, the iPro™2 system provides your physician with insights into how the nutrition plan, medication regimen and daily activities affect your glucose levels, enabling them to make more informed decisions regarding your diabetes management.
† Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns
¶ Only Guardian™ Connect Smart CGM and iPro2™ Professional CGM can be used without an insulin pump.
1 The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
2 Refers to Auto Mode. Some interaction required. Individual results may vary.
3 Guardian™ Sensor 3 Performance for the MiniMed™ 670G Insulin Pump. Sensor calibrated every 12 hours; within 30 minutes of event, both Low Threshold and Low Predictive alerts ON; with 41.7% false alert rate if the patient is unable to respond to the Suspend on Low alarm.
4 Grunberger G, Bailey TS, Cohen AJ, et al; and AACE Insulin Pump Management Task Force. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(4):746-762.
5 MiniMed™ 670G system is indicated for persons seven years of age and older. The Guardian™ Connect CGM system is indicated for persons 14 to 75 years of age.
# Based on sensor glucose.
Important Safety Information: MiniMed™ 670G System
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.
WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library.
Important Safety Information: iPro™2 Professional Continuous Glucose Monitoring (CGM)
The iPro™2 digital recorder is intended to continuously record interstitial glucose levels in persons with diabetes mellitus. This information is intended to supplement, not replace, blood glucose information obtained using standard home glucose monitoring devices. The information collected by the iPro™2 digital recorder may be uploaded to a computer (with Internet access) and reviewed by healthcare professionals. The information may allow identification of patterns of glucose-level excursions above and below a desired range, facilitating therapy adjustments, which may minimize these excursions.
See Instructions for Use (IFU) for additional details.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and http://www.medtronicdiabetes.com/importantsafetyinformation.
For proper instructions on inserting the Guardian™ sensor 3, visit the support webpage for inserting your sensor.
© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.